Ananta Khurana

2.7k total citations · 1 hit paper
100 papers, 1.7k citations indexed

About

Ananta Khurana is a scholar working on Dermatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ananta Khurana has authored 100 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Dermatology, 37 papers in Epidemiology and 21 papers in Infectious Diseases. Recurrent topics in Ananta Khurana's work include Nail Diseases and Treatments (32 papers), Dermatology and Skin Diseases (17 papers) and Autoimmune Bullous Skin Diseases (14 papers). Ananta Khurana is often cited by papers focused on Nail Diseases and Treatments (32 papers), Dermatology and Skin Diseases (17 papers) and Autoimmune Bullous Skin Diseases (14 papers). Ananta Khurana collaborates with scholars based in India, Netherlands and United States. Ananta Khurana's co-authors include Kabir Sardana, Anuradha Chowdhary, Ashutosh Singh, Chander Grover, Aradhana Masih, Pradeep Kumar Singh, Jacques F. Meis, Virendra Sehgal, Meenakshi Gupta and Ferry Hagen and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, PLoS Pathogens and Journal of the American Academy of Dermatology.

In The Last Decade

Ananta Khurana

91 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene

2018 249 citations Aradhana Masih, Ananta Khurana et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ananta Khurana India	22	1.1k	748	336	291	170	100	1.7k
Boaz Amichai Israel	20	592 0.5×	379 0.5×	502 1.5×	77 0.3×	162 1.0×	104	1.2k
Blanka Havlíčková Germany	12	895 0.8×	601 0.8×	394 1.2×	240 0.8×	33 0.2×	14	1.5k
Yang Won Lee South Korea	25	541 0.5×	208 0.3×	893 2.7×	95 0.3×	47 0.3×	110	1.6k
Elizabeth A. Cooper Canada	22	1.7k 1.6×	1.1k 1.5×	340 1.0×	271 0.9×	64 0.4×	51	2.0k
Fariba Iraji Iran	18	202 0.2×	138 0.2×	457 1.4×	53 0.2×	135 0.8×	83	936
Hilary Baldwin United States	25	271 0.2×	374 0.5×	1.5k 4.4×	94 0.3×	44 0.3×	120	1.8k
Federica Dall’Oglio Italy	16	316 0.3×	123 0.2×	454 1.4×	50 0.2×	60 0.4×	51	763
Ross StC. Barnetson Australia	22	383 0.3×	188 0.3×	642 1.9×	96 0.3×	121 0.7×	70	1.4k
Alvin B. Coda United States	10	270 0.2×	228 0.3×	998 3.0×	94 0.3×	304 1.8×	13	1.9k
Amir Hossein Siadat Iran	17	175 0.2×	108 0.1×	399 1.2×	75 0.3×	88 0.5×	83	903

Countries citing papers authored by Ananta Khurana

Since Specialization

Citations

This map shows the geographic impact of Ananta Khurana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ananta Khurana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ananta Khurana more than expected).

Fields of papers citing papers by Ananta Khurana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ananta Khurana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ananta Khurana. The network helps show where Ananta Khurana may publish in the future.

Co-authorship network of co-authors of Ananta Khurana

This figure shows the co-authorship network connecting the top 25 collaborators of Ananta Khurana. A scholar is included among the top collaborators of Ananta Khurana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ananta Khurana. Ananta Khurana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sardana, Kabir, et al.. (2025). Therapy resistant hypertrophic lichen planus and its response to oral tofacitinib with a priori tissue cytokine expression: a real-world hospital-based study. Archives of Dermatological Research. 317(1). 590–590. 1 indexed citations

Khurana, Ananta, et al.. (2024). Case Report: Mixed Airborne Contact Dermatitis–Chronic Actinic Dermatitis Pattern of Parthenium Dermatitis with Response to Tofacitinib Therapy. American Journal of Tropical Medicine and Hygiene. 110(6). 1276–1278.

Sardana, Kabir, et al.. (2024). Tofacitinib: A Treatment Option for Recalcitrant Polymorphic Light Eruption and Its Mechanistic Rationale. Dermatitis. 35(3). 246–249. 4 indexed citations

Khaitan, Binod K., et al.. (2024). ALOPECIA / HAIR LOSS. 2(1 Supp). S79–S80. 1 indexed citations

Khurana, Ananta, et al.. (2024). Trans‐epidermal extrusion of lepra bacilli from histoid lesions: a risk of continued transmission. International Journal of Dermatology. 63(4). 521–523. 1 indexed citations

Khurana, Ananta, et al.. (2023). Diagnosis of Leprosy: Current Updates and Future Directions. 1. 13–23. 3 indexed citations

Khurana, Ananta, et al.. (2023). Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae. Indian Journal of Dermatology. 68(5). 525–540. 14 indexed citations

Khurana, Ananta, et al.. (2023). Azathioprine Induced Pancytopenia with Pneumonia and Sepsis. Indian Journal of Dermatology. 68(2). 215–217.

Sardana, Kabir, Manjunath Shenoy, Madhu Rengasamy, et al.. (2023). IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole. Indian Dermatology Online Journal. 15(1). 1–7. 4 indexed citations

10.

Khurana, Ananta, et al.. (2022). Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris. JAMA Dermatology. 158(11). 1269–1269. 39 indexed citations

11.

Khurana, Ananta, et al.. (2021). Re‐emerging role of KOH smear examination in the era of recalcirant dermatophytoses. Dermatologic Therapy. 34(2). e14891–e14891. 5 indexed citations

12.

Khurana, Ananta, et al.. (2021). Efficacy of bleomycin as a treatment modality in pyogenic granuloma: a case series. Dermatologic Therapy. 34(4). e15024–e15024. 1 indexed citations

13.

Sardana, Kabir, et al.. (2020). Late leprosy reaction presenting as erythema multiforme-like erythema nodosum leprosum with underlying rifampicin resistance and its potential implications. International Journal of Mycobacteriology. 9(2). 226–226. 5 indexed citations

14.

Khurana, Ananta, et al.. (2020). Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences. International Journal of Infectious Diseases. 103. 549–551. 11 indexed citations

15.

Khurana, Ananta, et al.. (2020). Acquired dermal melanocytosis: Causing a rare but characteristic pattern of nasal alar pigmentation. Journal of Cosmetic Dermatology. 19(12). 3448–3450. 1 indexed citations

16.

Khurana, Ananta, Aradhana Masih, Anuradha Chowdhary, et al.. (2018). Correlation of In Vitro Susceptibility Based on MICs and Squalene Epoxidase Mutations with Clinical Response to Terbinafine in Patients with Tinea Corporis/Cruris. Antimicrobial Agents and Chemotherapy. 62(12). 94 indexed citations

17.

Khurana, Ananta, et al.. (2018). A pilot analysis of morphometric assessment of itraconazole brands using dermoscopy and its relevance in the current scenario. Indian Dermatology Online Journal. 9(6). 426–426. 30 indexed citations

18.

Grover, Chander, Ananta Khurana, Sambit Bhattacharya, & Arun Kumar Sharma. (2015). Controlled trial comparing the efficacy of 88% phenol versus 10% sodium hydroxide for chemical matricectomy in the management of ingrown toenail. Indian Journal of Dermatology Venereology and Leprology. 81(5). 472–472. 14 indexed citations

19.

Sehgal, Virendra, et al.. (2014). Basal cell carcinoma: pathophysiology.. PubMed. 12(3). 176–81. 17 indexed citations

20.

Khurana, Ananta, et al.. (2013). Telogen effluvium. Indian Journal of Dermatology Venereology and Leprology. 79(5). 591–591. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact